ZA200509661B - 9-Azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors - Google Patents

9-Azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors

Info

Publication number
ZA200509661B
ZA200509661B ZA200509661A ZA200509661A ZA200509661B ZA 200509661 B ZA200509661 B ZA 200509661B ZA 200509661 A ZA200509661 A ZA 200509661A ZA 200509661 A ZA200509661 A ZA 200509661A ZA 200509661 B ZA200509661 B ZA 200509661B
Authority
ZA
South Africa
Prior art keywords
azabicyclo
heteroatom
renin inhibitors
ene derivatives
ene
Prior art date
Application number
ZA200509661A
Other languages
English (en)
Inventor
Bezencon Olivier
Fischli Walter
Richard-Bildstein Sylvia
Sifferlen Thierry
Bur Daniel
Remen Lubos
Weller Thomas
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of ZA200509661B publication Critical patent/ZA200509661B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA200509661A 2003-04-30 2005-11-29 9-Azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors ZA200509661B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP0304492 2003-04-30

Publications (1)

Publication Number Publication Date
ZA200509661B true ZA200509661B (en) 2006-11-29

Family

ID=33395690

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200509661A ZA200509661B (en) 2003-04-30 2005-11-29 9-Azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors

Country Status (13)

Country Link
US (1) US20060258648A1 (xx)
EP (1) EP1622685A1 (xx)
JP (1) JP2006524655A (xx)
KR (1) KR20060008937A (xx)
CN (1) CN1780663A (xx)
AU (1) AU2004233575A1 (xx)
BR (1) BRPI0409884A (xx)
CA (1) CA2521938A1 (xx)
MX (1) MXPA05011498A (xx)
NO (1) NO20054974L (xx)
RU (1) RU2005137155A (xx)
WO (1) WO2004096366A1 (xx)
ZA (1) ZA200509661B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2540817A1 (en) * 2003-10-23 2005-05-06 Olivier Bezencon Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
AU2004295092A1 (en) * 2003-12-05 2005-06-16 Actelion Pharmaceuticals Ltd. Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain
WO2006021403A1 (en) * 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Bicyclononene derivatives
JP2008510755A (ja) 2004-08-25 2008-04-10 アクテリオン ファーマシューティカルズ リミテッド ビシクロノネン誘導体
WO2006058546A1 (en) * 2004-12-01 2006-06-08 Actelion Pharmaceuticals Ltd Novel lactame derivatives as renin inhibitors
WO2006063610A1 (en) * 2004-12-17 2006-06-22 Actelion Pharmaceuticals Ltd Heteroaryl substituted diazabicyclononene derivatives
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
AU2006332124B2 (en) 2005-12-30 2011-03-03 Novartis Ag 3 , 5-substitgammaued piperidine compounds as renin inhibitors
EP1981847A1 (en) 2006-02-02 2008-10-22 Actelion Pharmaceuticals Ltd. Secondary amines as renin inhibitors
WO2007104652A2 (en) * 2006-03-16 2007-09-20 Nicox S.A. Non-peptidic renin inhibitors nitroderivatives
WO2008141462A1 (en) 2007-05-24 2008-11-27 Merck Frosst Canada Ltd. Novel case of renin inhibitors
WO2009000811A1 (en) 2007-06-25 2008-12-31 Novartis Ag N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
JP2010536800A (ja) 2007-08-20 2010-12-02 メルク フロスト カナダ リミテツド レニン阻害剤
WO2009071449A1 (en) 2007-12-05 2009-06-11 Basf Se Pyridylmethyl-sulfonamide compounds
MY152042A (en) 2008-05-05 2014-08-15 Actelion Pharmaceuticals Ltd 3,4- substituted piperidine derivatives as renin inhibitors
ATE540957T1 (de) * 2008-11-25 2012-01-15 Univ Firenze Bicyclische peptidomimetikum-inhibitoren von aspartylproteasen zur behandlung von infektionskrankheiten
CN102093389B (zh) * 2009-12-09 2014-11-19 华东理工大学 双联和氧桥杂环新烟碱化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509161A (en) * 1967-07-10 1970-04-28 Boehringer & Soehne Gmbh 3-phenyl-granatene-(2)-derivatives
US5380758A (en) * 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
CN1256326C (zh) * 1995-09-07 2006-05-17 弗·哈夫曼-拉罗切有限公司 治疗心脏和肾功能不全的新型4－(氧烷氧基苯基)－3－氧哌啶化合物
BR0309498A (pt) * 2002-04-29 2005-02-15 Actelion Pharmaceuticals Ltd Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças que são relacionadas com o ras, e, uso de compostos
AU2003229746A1 (en) * 2002-06-27 2004-01-19 Actelion Pharmaceuticals Ltd Novel tetrahydropyridine derivatives as renin inhibitors

Also Published As

Publication number Publication date
CA2521938A1 (en) 2004-11-11
EP1622685A1 (en) 2006-02-08
NO20054974D0 (no) 2005-10-26
AU2004233575A1 (en) 2004-11-11
US20060258648A1 (en) 2006-11-16
WO2004096366A1 (en) 2004-11-11
KR20060008937A (ko) 2006-01-27
BRPI0409884A (pt) 2006-05-23
NO20054974L (no) 2005-11-28
JP2006524655A (ja) 2006-11-02
MXPA05011498A (es) 2005-12-15
RU2005137155A (ru) 2006-03-27
CN1780663A (zh) 2006-05-31

Similar Documents

Publication Publication Date Title
ZA200509661B (en) 9-Azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors
PL372123A1 (en) Thiazole derivatives
LT3002283T (lt) Tiazolo dariniai
AU2003262023A1 (en) Five-membered heterocyclic compounds
SI1343773T1 (sl) Tiazolni derivati za zdravljenje motenj v zvezi s PPAR
PL375747A1 (en) 1, 3-diamino-2-hydroxypropane prodrug derivatives
AU2003255492A1 (en) Heterocyclic derivatives
PL377295A1 (pl) Pochodne 4,5-diarylotiazolu jako ligandy CB-1
PL350179A1 (en) C-21 modified epothilones
PL356484A1 (en) Thiazolyl amide derivatives
ZA200408423B (en) Novel tetrahydropyridine derivatives as renin inhibitors.
AU2003205731A1 (en) Mono- and biacylphosphine derivatives
PL375416A1 (en) Thiazole derivatives
HUP0300562A3 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the
MXPA02005011A (es) Nuevos derivados de tiazolidindiona como agentes antidiabeticos.
EP1501811A4 (en) PROCESS FOR THE PREPARATION OF THIAZOLE DERIVATIVE AND INTERMEDIATE COMPOUNDS THEREFOR
AU2002253456A8 (en) Azole derivatives as antifungal agents
AU2003294938A8 (en) Epothilone derivatives
AU5116000A (en) Device by tool adapted to change the drilling direction while drilling
AU2003280578A1 (en) Heterocyclic compounds
AU2002953019A0 (en) Azole derivatives
AU2003273169A1 (en) 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
EP1409268A4 (en) ACCESSORY FOR WRITING OR SIMILAR INSTRUMENT
AU2003285600A1 (en) Process for the preparing ziprasidone monohydrochloride hydrate
GB0226609D0 (en) Heterocyclic derivatives